[{"countryName":"Global","languageLinks":[{"languageName":"English","languageUrl":"/en/expecting-parents.html"}]},{"countryName":"Global","languageLinks":[{"languageName":"Spanish","languageUrl":"/es/expecting-parents.html"}]},{"countryName":"United States","languageLinks":[{"languageName":"English","languageUrl":"https://diagnostics.roche.com/us/en/products/other/harmony-clinicians.html"}]},{"countryName":"Italy","languageLinks":[{"languageName":"Italiano","languageUrl":"/it-it/expecting-parents.html"}]},{"countryName":"Germany","languageLinks":[{"languageName":"Deutsch","languageUrl":"http://harmonytest.de/"}]},{"countryName":"Hong Kong","languageLinks":[{"languageName":"中文","languageUrl":"http://www.harmonytest.hk/zh-hk.html"},{"languageName":"English","languageUrl":"http://www.harmonytest.hk/en-hk.html"}]},{"countryName":"Japan","languageLinks":[{"languageName":" 日本人","languageUrl":"/ja-jp/expecting-parents.html"}]}]
Your are moving out from Worldwide Website
clinicians.popup.message
You are Moving to an External Website.
You are entering the website withbut you have selected some other country as default. Do you want to continue?
COVID-19 Impact and mitigation strategies for prenatal screening for aneuploidy.
Date: 8 June, 2020
Speakers: Prof. Maria del Mar Gil & Prof. Liona Poon
Comparison of Genome-Wide versus Targeted cfDNA Testing for First-Line Prenatal Screening: Real-World Data
Date: 18 March, 2020
Speaker: Dr. Elisa Bevilacqua
22q11.2 Deletion Syndrome: Ultrasound Features and Opportunities for Screening Using cfDNA
Date: 15 October, 2019
Speaker: Dr. Rabih Chaoui
Cell-free DNA Testing for Fetal Aneuploidy: Lessons Learned and Implications for Clinical Practice
Date: 25 July, 2019
Speaker: Prof. Kypros Nicolaides
Genome-wide NIPT for Rare Chromosomal Conditions: Technical, Biological, and Clinical Considerations
Date: 19 June, 2019
Speaker: Dr. Francesca Romana Grati
